Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-14

Clinical Trial Update: HIV Drug Switch Followed by HCV Therapy in HIV-HCV Co-Infection [Phase 3]

View source ↗

Summary

Phase 3 trial update on switching HIV therapy followed by Hepatitis C treatment in people co-infected with HIV and Hepatitis C; completed study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Human Immunodeficiency Virus, Hepatitis C, Chronic | Phase 3 | Status: COMPLETED